The context-dependent duality of HF, such as its opposing roles in the AKT/STAT3 pathway in cancer cells versus stressed hepatocytes, demands a systems-level understanding using multi-omics approaches and genetically engineered animal models to identify predictive biomarkers for patient stratification. The gene discussed is STAT3; the disease is cancer.